PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

LinkedIn

Tyenna Injection Recalled for Glass Contamination

Medication Safety / Pharmacovigilance

Background Information

Alert: Tyenne Injection recall due to glass particles risk.

Injectable products containing glass particles can cause serious health risks including blood clots and organ damage. A nationwide recall of Tyenne (tocilizumab-aazg) Injection due to glass particle contamination was issued. Pharmacists must identify and remove affected vials from inventory, and prevent further dispensing. Recall alert for Tyenne injection due to contamination with glass particles.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

View on PubMed →

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
Full deep analysis for this article is still in progress. Check back soon.